Sign In
Buy PET
$0.0469
+0 (+0%)
At Close: Oct 28, 2025
Wag! Group Co. (PET) Q1 2025 Earnings Call Transcript
11:34am, Monday, 12'th May 2025
Wag! Group Co. (NASDAQ:PET ) Q1 2025 Earnings Conference Call May 12, 2025 8:30 AM ET Company Participants Greg Robles - IR Garrett Smallwood - CEO and Chairman Adam Storm - President and Chief Produc
NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies w
Telix's Illuccix PSMA-PET Imaging Agent Approved in France
06:30pm, Monday, 28'th Apr 2025
New approval provides French hospitals and clinics with access to a proven PSMA-PET imaging agent New approval provides French hospitals and clinics with access to a proven PSMA-PET imaging agent
TORONTO, April 01, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) “Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to buildi
Wag! Group Co. (PET) Q4 2024 Earnings Call Transcript
09:31am, Monday, 24'th Mar 2025
Wag! Group Co. (NASDAQ:PET ) Q4 2024 Earnings Conference Call March 24, 2025 8:30 AM ET Company Participants Greg Robles - IR Garrett Smallwood - Chairman & CEO Adam Storm - President & Chief Product
Wag! Reports Fourth Quarter and Full Year 2024 Results; Announces Review of Strategic Alternatives to Maximize Shareholder Value
07:00am, Monday, 24'th Mar 2025
SAN FRANCISCO, March 24, 2025 (GLOBE NEWSWIRE) -- Wag! Group Co. (the “Company” or “Wag!”; Nasdaq: PET), which strives to be the number one platform to solve the service, product, and wellness
Wag! To Report Fourth Quarter and Full Year 2024 Financial Results on March 24, 2025
04:05pm, Tuesday, 18'th Mar 2025
SAN FRANCISCO, March 18, 2025 (GLOBE NEWSWIRE) -- Wag! Group Co., (the “Company” or “Wag!”, Nasdaq: PET), which strives to be the number one platform to solve the service, product, and wellnes
Considering delayed non-dilutive sources of financing, CARBIOS postpones construction of its Longlaville PET biorecycling plant for 6 to 9 months
Origin Materials Continues Commercial Qualification, Announces Production of Caps with New Features
07:00am, Wednesday, 18'th Dec 2024
WEST SACRAMENTO, Calif.--(BUSINESS WIRE)--Origin Materials (“Origin”) (NASDAQ: ORGN, ORGNW), a technology company with a mission to enable the world's transition to sustainable materials, today an
Contineum Therapeutics Initiates Patient Dosing in Phase 1b Positron Emission Tomography (PET) Trial of PIPE-791
04:05pm, Monday, 16'th Dec 2024
SAN DIEGO--(BUSINESS WIRE)--Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small m
Wag! Group Co. (PET) Q3 2024 Earnings Call Transcript
04:07pm, Wednesday, 13'th Nov 2024
Wag! Group Co. (NASDAQ:PET ) Q3 2024 Results Conference Call November 13, 2024 8:30 AM ET Company Participants Greg Robles - Investor Relations Garrett Smallwood - Chief Executive Officer Adam Storm -
Wag! Group Co. (PET) Reports Q3 Loss, Lags Revenue Estimates
09:36am, Wednesday, 13'th Nov 2024
Wag! Group Co. (PET) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to loss of $0.06 per share a year ago.
Wag! Reports Third Quarter 2024 Results
07:00am, Wednesday, 13'th Nov 2024
SAN FRANCISCO, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Wag! Group Co. (the “Company” or “Wag!”; Nasdaq: PET), which strives to be the number one platform to solve the service, product, and wellness
PROUD PET PARENTS TEAM UP WITH GLOBAL SUPERSTAR MEGHAN TRAINOR AND FRESHPET TO SUPPORT ANIMAL SHELTERS
09:00am, Tuesday, 01'st Oct 2024
Freshpet launches its first apparel collection in collaboration with the singer just in time for the holidays, with 100% of proceeds going to animal rescues BEDMINSTER, N.J. , Oct. 1, 2024 /PRNewswire
ARLINGTON HEIGHTS, Ill.--(BUSINESS WIRE)--GE HealthCare announces FDA approval of Flyrcado (flurpiridaz F 18) injection PET radiotracer for enhanced diagnosis of coronary artery disease.
